MarketsStocksSHUKRAPHAR
SH

Shukra Pharmaceuticals Limited

NSE: SHUKRAPHARBSE: 524632Healthcare
Download Research Report7-page PDF
31.98
+1.65%
NSE · auto-updates while market open
Mkt Cap
₹140 Cr
P / E
4.8
P / B
1.6
ROE
38.2%
52W High
₹65.26
52W Low
₹12.97
Key Metrics
Market Cap
₹140 Cr
P / E
4.80
P / B
1.55
EV / EBITDA
4.76
ROCE
45.8%
ROE
38.2%
Debt / Equity
0.06
Book Value
₹20.52
EPS
₹0.50
Div Yield
0.0%
Face Value
-
Promoter Holding
51.0%
Revenue · ₹ Cr
20
FY22
59
FY23
75
FY24
33
FY25
57
FY26
Net Profit · ₹ Cr
1
FY22
4
FY23
19
FY24
10
FY25
22
FY26
EPS · ₹ per share
₹4.8
FY22
₹26.2
FY23
₹16.9
FY24
₹0.2
FY25
₹0.5
FY26
Q4 2025 snapshot
Sales
₹40 Cr
Operating profit
-
OPM
-
Net profit
₹20 Cr
EPS
₹0.47
Scorecard · 7 axes
Quality
Strong
99/100
Valuation
Strong
4.8×
Growth
Strong
+80.9%
Profitability
Strong
42.0%
Performance
Strong
+132.7%
Entry Point
Strong
49%
Red Flags
Strong
0 flags
Shareholding Pattern
51.0%Promoter
Promoter51.0%
DII0.1%
Public48.9%
Quarterly Results · ₹ Cr
QuarterFY24 09QFY24 12QFY25 03QFY25 06QFY25 09QFY25 12Q
Revenue6.5711.5914.746.57.5939.95
Net Profit0.5393.1645.3871.032.37820.365
NPM %8.2%27.3%36.5%15.8%31.3%51.0%
AlertPre-trade